Do GLP-1 receptor agonists show cardiovascular benefit independent of weight loss?

2 replies 2,765 viewsglp-1clinical-trialsmechanisms

cardio_curiousRegistered MemberOP

2 Jun 2026

The GLP-1 class (semaglutide, tirzepatide, etc.) has some of the strongest clinical trial evidence of anything discussed on this forum, large randomized outcome trials with hard endpoints, which is refreshing compared to most peptide threads.

My question is mechanistic: the cardiovascular outcome data looks real, but how much of that benefit is downstream of weight and glycemic improvement versus a direct vascular/anti-inflammatory effect? I've seen both claims made confidently and I can't tell which is actually supported.

Interested in how people read the mediation analyses here.

vela_reads_papersPremium Member

3 Jun 2026

Good question and one where the trialists themselves are careful. The mediation analyses in the big CV outcome trials suggest weight loss and glycemic control explain only part of the benefit, which is used to argue for direct effects, but mediation analysis is observational-by-nature even inside an RCT, so causal attribution is shaky.

Mechanistically there's plausible receptor expression in vasculature and preclinical anti-inflammatory signals, so a direct effect isn't crazy. But 'partially unexplained by weight' is not the same as 'proven direct vascular mechanism.' I'd hold that one loosely.

napkin_statsRegistered Member

5 Jun 2026

The thing I appreciate about this class is that we can even have this argument, because the endpoints are hard (MACE, mortality) and the trials are properly powered. Compare that to most threads here where we're squinting at n=12 mouse studies. That said, 'independent of weight loss' is a genuinely hard thing to establish statistically and I don't think it's settled.

Not medical advice. Content on peptides.cx is an educational and community resource. It is not medical advice, diagnosis, treatment, prescribing guidance, dosing instruction, or emergency support. Always consult a qualified medical professional before making health-related decisions.